Liver diseases are fast emerging as global health priorities. Fatty liver is described in the
setting of non-alcoholic fatty liver disease (NAFLD) as well as alcoholic liver disease (ALD) …

Nonalcoholic fatty liver disease (NAFLD) and alcohol-related liver disease (ALD) are the
leading causes of chronic liver disease worldwide. NAFLD and ALD share …

This guidance provides a data‐supported approach to the diagnostic, therapeutic, and
preventive aspects of nonalcoholic fatty liver disease (NAFLD) care. A “Guidance” document …

These recommendations are based on the following:(1) a formal review and analysis of the
recently published world literature on the topic [Medline search up to June 2011];(2) the …

Guidelines; 1 (3) guideline policies of the three societies approving this document; and (4)
the experience of the authors and independent reviewers with regards to NAFLD. Intended …

The epidemic of obesity has resulted in a parallel incremental burden of nonalcoholic fatty
liver disease (NAFLD) worldwide. Nonalcoholic fatty liver disease includes a spectrum of …

Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) are
increasingly relevant public health issues owing to their close association with the …

Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease
worldwide, with a prevalence of 25–30%. Since its first description in 1980, NAFLD has …

Non-alcoholic fatty liver disease (NAFLD) is the most frequent cause of liver disease in the
Western world. Furthermore, it is increasing worldwide, paralleling the obesity pandemic …

Histological analysis of liver biopsies remains a standard against which other methods of
assessment for the presence and amount of hepatic injury due to nonalcoholic fatty liver …